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ABSTRACT 
K+-INDUCED SMOOTH MUSCLE CALCIUM SENSITIZATION 
REQUIRES RHOA KINASE (ROK) TRANSLOCATION TO 
CAVEOLAE WHICH IS INHIBITED IN NON-NEURONAL CELL 
MEMORY
Nicole Hairrell Urban 
Old Dominion University and Eastern Virginia Medical School, 2000
Chair: Dr. Paul H. Ratz
KC1 causes smooth muscle contraction by elevating intracellular free calcium 
([Ca2+]i), while receptor stimulation activates an additional mechanism termed Ca2+- 
sensitization that can involve activation of ROK and PKC. However, recent studies 
support the hypothesis that KC1 may also increase Ca2+-sensitivity (36). Our data showed 
that the PKC inhibitor, GF-109203X, did not, while the ROK inhibitor, Y-27632, did 
inhibit KCl-induced tonic (5’) force and myosin light chain (MLC) phosphorylation in 
rabbit artery. Y-27632 also inhibited Bay K-8644- and ionomycin-induced MLC 
phosphorylation and force, but did not inhibit KCl-induced calcium entry or peak (~15”) 
force. Moreover, KC1 and Bay K-8644 nearly doubled the amount o f ROK colocalized to 
caveolae at 30”, a time that preceded inhibition of force by Y-27632. Colocalization was 
not inhibited by Y-27632, but was abolished by nifedipine and the calmodulin blocker, 
trifluoperazine. Since, -30%  of RhoA is colocalized with caveolin basally, these data 
suggest a novel model for Ca2+-activated Ca2+-sensitization, elicited by KC1 contraction, 
that involves Ca2+/cam dependent ROK translocation to caveolae and activation by 
RhoA.
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Our laboratory previously showed that the degree of force produced for a given 
KCl-induced increase in [Ca2+]i can be substantially altered by the history of receptor 
stimulation termed “non-neuronal cell memory”, because the vascular smooth muscle 
cells stored information temporarily about the degree of prior activation (75). PE 
pretreatment inhibited of ROK translocation to caveolae in the subsequent KC1 
contraction and caused an increase in inactive RhoA. PKG activation also caused a 
similar inhibition of the RhoA/ROK signaling pathway. Ca2+-desensitization elicited by 
PP1 inhibition caused caveolar internalization and inhibited of ROK translocation. PKG 
was also found to cause caveolar internalization, supporting the hypothesis that caveolar 
maintenance is kinase-mediated. These data support the hypothesis that the information 
storage method utilized in non-neuronal cell memory involves an inhibition of the 
RhoA/ROK pathway. Moreover, these data support the hypothesis that caveolae are loci 
for signal transduction pathways, and suggest that the membranous location of caveolae 
is an important factor in RhoA/ROK-mediated Ca2+-sensitization.
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TERM OR ABREV. DEFINITION
Ca2+ calcium
[Ca2+]j intracellular free calcium
MLC myosin light chain
RLC regulatory light chain of myosin II





CPI-17 protein kinase C-potentiated inhibitory protein
MYPT1 myosin phosphatase targeting subunit
RHOA small GTPase involved in Ca2+-sensitization
RHOGDI guanine nucleotide dissociation inhibitor of RhoA
GEF guanine nucleotide nucleotide exchange factor
GAP GTPase accelerating protein
ROK RhoA kinase, effector o f RhoA
cAMP cyclic adenosine monophosphate
PKA protein kinase A
cGMP cyclic guanosine monophosphate
PKG protein kinase G
NO nitric oxide
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
EGF epidermal growth factor
eNOS endothelial nitric oxide synthase
LSM laser scanning (confocal) microscope
PMT photomultiplier tube
CAM calmodulin
KC1 potassium chloride, depolarizes and contracts smooth muscle
PE phenylephrine, a-adrenergic agonist




NIFEDIPINE L-type calcium channel inhibitor
BAY K-8644 L-type calcium channel agonist
IONOMYCIN calcium ionophore
TFP trifluoperazine, calcium/calmodulin inhibitor
8BR-cGMP cell permeable activator of PKG
PP1 protein phosphatase 1
OA okadaic acid, PP1 inhibitor
NAF sodium fluoride, PP1 inhibitor




An abnormal state of increased contraction of vascular smooth muscle is thought 
to play a role in hypertension, coronary and cerebral vasospasm and vascular smooth 
muscle cell proliferation (1). Recent studies suggest that the small GTPase RhoA and its 
effector RhoA kinase (ROK) play a major role in the regulation of vascular smooth 
muscle contraction by modulating the Ca2+-sensitivity of myosin II. Ca2+-sensitization, 
via the RhoA/ROK signaling pathway involves the inhibition of myosin light chain 
(MLC) phosphatase, the protein responsible for dephosphorylating the regulatory light 
chain of myosin II, which leads to the tonic (sustained contraction) phase of agonist- 
induced contractions (1). A further understanding of the mechanisms leading to Ca2+- 
sensitization of smooth muscle is an important step in the development o f treatments for 
vascular diseases.
This dissertation follows the style of Circulation Research.
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CHAPTER II
ORGANIZATION AND CONTRACTION IN MUSCLE
II. 1 Skeletal Muscle
The organization and contractile process of smooth muscle is quite different than 
that of skeletal muscle. Skeletal muscle is composed of bundles of multinucleated cells 
organized into fibers comprised of successively smaller subunits. Skeletal muscle fibers 
have a bandlike pattern due to a highly organized subcellular structure which led to the 
term striated muscle. The striated pattern o f skeletal muscle is due to the repeating 
pattern of two sets of filaments in the bundles. The sarcomere is the basic unit of skeletal 
muscle structure which extends from one Z-line to the next and is composed of myosin 
fibers called thick filaments and actin fibers called thin filaments. The thin filaments 
attach to Z-lines and partially interdigitate into the myosin filaments giving the myofibril 
its alternating dark and light bands (2).
The thin filament is composed of two actin filaments wound in an a-helix. One 
strand of tropomyosin is loosely associated with the actin backbone and is thought to 
cover the active sites on actin. Troponin is a complex of three proteins that participates 
in the control of skeletal muscle contraction. The complex is composed of one subunit of 
each troponin I, which has a strong affinity for actin; troponin T, which has an affinity for 
tropomyosin; and troponin C which binds calcium (Ca2+) ions.
Each myosin molecule, or thick filament, is composed of one set o f two heavy 
chains (~200kDA each) and two sets of light chains (~20kDa each). The C-terminal of 
each heavy chain forms a long a-helical tail, and the two tails associate to form a left- 
handed coiled coil. The N-terminal half o f each heavy chain has a globular tertiary
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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structure, called the head region, which contains the actin binding domain and the ATP- 
binding site. A flexible neck region is located between the head and tail regions and 
contains two calmodulin-like light chains. Several hundred myosin molecules aggregate 
to form the thick filament. The tails are packed in a bipolar staggered array where the 
heads protrude from each end and the center is a bare zone. The protruding head regions 
of the filaments, called crossbridges, link adjacent thin and thick filaments.
In skeletal muscle, an action potential in the cell membrane causes the Ca2+ 
concentration in the intracellular space to rise. Ca binding to troponin causes a thin 
filament conformational change revealing the binding site for myosin on actin and allows 
the proteins to interact. As Ca2+ is removed from the intracellular space and dissociates 
from troponin, the thin filament returns to its original conformation and contraction 
ceases (3). The myosin heavy chain is an ATPase that hydrolyzes ATP to ADP and Pi to 
power muscle contraction. Briefly, the binding of ATP to myosin results in the 
dissociation of actin and myosin. The ATP is rapidly hydrolyzed to form myosin-ADP- 
Pi, which is the “high energy” conformation of myosin wherein the myosin head 
undergoes a conformational change and becomes “cocked.” Next myosin-ADP- Pj 
weakly binds actin, and a release of Pj causes a stronger binding o f myosin-ADP to actin. 
Subsequent release of ADP is the “power stroke” because myosin returns to its original 
conformation while still bound to actin. Myosin can then undergo another round of ATP 
hydrolysis. This describes the “walking” of myosin up the actin filament, and the 
sequential binding and release of actin by myosin results in muscle contraction.
Therefore, in skeletal muscle, unlike smooth muscle, the activation of troponin by Ca2+ is 
necessary and, in the presence of ATP, sufficient to cause contraction.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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II.2 Smooth Muscle
Smooth muscle cells are usually 20 to 500 gm in length and two to five pm in 
diameter and lack the striated appearance of skeletal muscle cells. There are two types of 
smooth muscle; multi-unit and unitary smooth muscle. Multi-unit smooth muscle is 
similar to skeletal muscle in that each cell can act independently and can be innervated by 
a single nerve ending. Multi-unit smooth muscle exists in the ciliary muscle of the eye 
and in the nictitating membrane in some lower animals, and is mainly controlled by 
nervous signals. In unitary smooth muscle, the fibers are aggregated into bundles or 
sheets and hundreds to thousands of muscle fibers contract together. Unitary smooth 
muscle, also called syncytial or visceral smooth muscle, is found in the vasculature and in 
the walls of most viscera of the body such as urinary bladder, gut, ureters and uterus.
Gap junctions join adjacent cells so that ions can flow from one cell to another. 
Intercellular protein bridges exist between the dense bodies, which serve the same 
function as the Z lines in skeletal muscle, to allow for force transmission from one cell to 
another. Actin filaments are attached to dense bodies, some of which anchor the 
cytoskeleton to the cell membrane. The interaction of actin and myosin governs smooth 
muscle contraction, but the troponin complex requisite for skeletal muscle contraction is 
absent in smooth muscle (3).
Whereas skeletal muscle contraction which is governed by membrane potential 
control and the binding of calcium to a troponin, smooth muscle is not only regulated by 
a similar electromechanical coupling, but also by pharmomechanical coupling (4). 
Contractile stimuli cause an increase in intracellular free calcium ([Ca2+];) from both 
extracellular stores, via non-specific cation channels and L-type voltage operated
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channels, and intracellular stores (sarcoplasmic reticulum). This increase in [Ca2+]j 
causes an increase in Ca2+ binding to calmodulin which results in activation of myosin 
light chain (MLC) kinase. MLC kinase phosphorylates the myosin 20kDa regulatory 
light chain (RLC). Smooth muscle MLC kinase is composed of a kinase catalytic core
94 -and a regulatory segment containing both a Ca /calmodulin-binding sequence and an 
autoinhibitory segment. The autoinhibitory sequence prevents the binding o f RLCs but
94 -not ATP. When activated by Ca , calmodulin binds to MLC kinase at the
9  I
Ca /calmodulin-binding sequence, and the autoinhibitory segment is displaced from the 
catalytic core. This allows binding of the RLC and transfer o f the phosphate from ATP 
to RLC on Ser19 which results in cross-bridge cycling and the production of contractile 
force (reviewed by 4,5,6 ,7). Smooth muscle MLC kinase has a different catalytic 
specificity than the skeletal muscle form, and in smooth muscle, MLC phosphorylation is 
sufficient to initiate contraction (8), but studies show that the regulation o f contraction 
can not be fully explained by Ca2+-activation of MLC kinase in all smooth muscle types 
(9, 10 and reviewed by 4).
A second smooth muscle regulatory system involving sensitization of contractile 
proteins to Ca2+ is now known to be responsible for an elevation in the degree of 
contractile force without further increases in [Ca2+]j, and is termed Ca2+-sensitization (6 ,
5, 11). Proof of the existence of Ca2+-sensitization was found in studies utilizing 
permeabilized smooth muscle cells, which allow the [Ca2+]j to be held at a constant level. 
Studies demonstrated that in the presence of GTP, contractions could be elicited by 
agonists at a constant [Ca2+]i (5,12, 13). Therefore, smooth muscle contraction is 
dependent not only on [Ca2+]; and the Ca2+/calmodulin-dependent activation of MLC
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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kinase, but also the Ca2+-sensitivity (elevated degree of contractile force per unit of 
[Ca2+]; of the contractile apparatus) (6 , 5, 11,14).
II.3 Calcium Sensitization in Smooth Muscle
There are two generally accepted mechanisms proposed to govern Ca2+- 
sensitization; regulation of the thin filament-associated proteins, called thin filament 
regulation, and regulation of MLC phosphorylation primarily via alterations in MLC 
phosphatase activity. Thin filament regulation suggests that the cross-bridges between 
actin and myosin are regulated by thin filament-associated proteins, such as calponin and 
caldesmon. Many of these studies investigate the inhibition o f actin and myosin 
interactions and the effects of thin filament-associated proteins on cross-bridge cycling 
rates. Data that support this hypothesis include studies that indicate cross-bridge cycling 
rates can vary without concomitant changes in MLC phosphorylation, and studies 
showing a dissociation between tension (force) and MLC phosphorylation (15,16 and 
reviewed by 17; 18, 19). Data suggest that caldesmon tethers and aligns actin and 
myosin, but interferes with their interaction until contraction is elicited by receptor 
agonists. Other studies show that calponin participates in the signaling pathway of 
protein kinase C (PKC) activation (see Fig 1, page 7 for pathway). A complicating factor 
in thin filament regulation research is the issue of significant variances in results from 
different species and tissues. Studies also find opposing results with different agonists 
(reviewed by 20).
Although the precise signaling mechanisms which govern Ca2+-sensitization are 
not known, many proposed mechanisms converge on the regulation of MLC phosphatase 
rather than on the regulation of thin filaments. Furthermore, some of the signaling
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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molecules involved in Ca -sensitization due to MLC phosphatase inhibition have been
linked to pathophysiological conditions such as high blood pressure and cerebral
vasospasm and could be targets for therapeutic strategies (reviewed by 21).
Ca2+-sensitization due to MLC phosphatase inhibition is produced by agents that
activate G-protein-coupled receptors, phorbol esters, and arachidonic acid. Activation of
2_|_ . . .  .
G protein-coupled receptors, by Ca -sensitizing agonists, results in the activation of 
phospholipase CP (PLC). PLC mediates the hydrolysis of phosphatidylinositol-4,5-bis- 
phosphate (PIP2) into inositol-1,4,5-trisphosphate (IP3) and 1,2-diacylglycerol (DAG).
IP3 causes the release of calcium from the sarcoplasmic reticulum (SR) which results in 
an increase in [Ca2+]i and activation of M LC kinase. D A G  and Ca2+ activate protein
kinase C (PKC) (Fig 1).
' f i c a p
IPs
c o h tm c t
PLPIPMLCK





94-Figure 1. Model o f  G protein-activated Ca -sensitization.
0+PKC plays a role in the Ca -sensitization elicited by G-protein coupled receptor 
activation by decreasing MLC phosphatase activity (reviewed by 22). PKC inhibits
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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MLC phosphatase by activating the 17 kDa protein kinase C-potentiated inhibitory
38protein (CPI-17) by phosphorylating it on threonine . MLC phosphatase is composed of 
three subunits; a 37 kDa catalytic subunit of protein phosphatase type 15 (PPlc), a large 
130 kDa myosin binding or targeting subunit (MYPT1), and a 20 kDa noncatalytic 
subunit of unknown function. Activated CPI-17 phosphorylates the PP1 subunit of 
MLCP which results in dissociation of the MLC phosphatase subunits and inactivation of 
the enzyme (23, 24, 25, 26 and reviewed by 21). Studies indicate that PKC may play a 
lesser role than the protein RhoA in agonist-induced Ca -sensitization (reviewed by 1).
II.4 RhoA Function and Regulation
RhoA is a member of the Ras superfamily of small monomeric GTPases. RhoA 
functions as a molecular switch as it cycles between an inactive, GDP-bound state and an 
active GTP-bound state. RhoA is cyclically regulated such that in resting cells RhoA is 
bound to Rho guanosine nucleotide dissociation inhibitor (RhoGDI). RhoGDI inhibits 
the exchange of GTP for GDP thereby inhibiting RhoA from becoming active.
RhoA can be activated by several G-proteins such as G a ^ n , Gaq and Ga;_2 
depending on the cell type and agonist involved (27, 28 and reviewed by 21). When a 
cell is stimulated, guanine nucleotide exchange factors (GEFs) stimulate the exchange of 
GTP for GDP on RhoA resulting in the targeting o f GTP-RhoA to the membrane. When 
RhoA has activated its target and is in the GDP-RhoA conformation, RhoGDI binds 
GDP-RhoA and extracts it from the cell membrane. Therefore, RhoA cycles from an 
inactive, cytosolic RhoGDI-bound form and an activated membrane-bound form. In the 
cytosol, the geranyl-geranylated (hydrophibic) tail of RhoA inserts into a hydrophiboc 
cavity o f RhoGDI. This binding is reinforced by protein-protein interactions between the
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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highly conserved GDI-binding site on RhoA and the N-terminus of RhoGDI (21). RhoA 
activity is also regulated by GTPase-activating proteins (GAPs). GAPs accelerate the 
intrinsic GTPase of RhoA, speeding the conversion of active GTP-RhoA to inactive 
GDP-RhoA (1).
RhoA is involved in the regulation of a number of cell processes which regulate 
cell morphology, cell aggregation, membrane ruffling, stress-fiber formation and focal- 
adhesion formation. In smooth muscle cells, RhoA participates in the regulation of cell 
contraction as a major player in G protein-coupled receptor elicited Ca2+-sensitization. 
The effects of RhoA are thought to be mediated in large part through its effector ROK 
(reviewed by 21).
II.5 ROK Function and Regulation
Ttwo isoforms of ROKhave been identified; ROKa/ROCK II and ROKp/ROCK I 
which are 150-160 kDa. ROK isoforms have an N-terminal kinase domain, a central 
coiled-coil domain, and a C-terminal pleckstrin homology (PH) domain which has a 
cysteine-rich zinc finger insert. The Rho-binding (RB) domain is located in the coiled- 
coil domain (29). Data suggests that for ROK to become activated by RhoA, GTP-bound 
RhoA binds to the Rho binding domain of ROK. Studies suggest that RhoA binds to the 
Rho binding domain of ROK results in a conformational change in ROK that disrupts the 
autoinhibitory interaction between the kinase domain and the catalytic domain (30).
Whereas PKC (via the actions of CPI-17) inhibits MLC phosphatase by 
phosphorylating the PP1 subunit resulting in dissociation of the MLC phosphatase 
enzyme, ROK phosphorylates the MYPT1 subunit of MLC phosphatase inhibiting its 
phosphatase activity. This results in an increase in MLC phosphorylation and thus
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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contractile force in smooth muscle (Fig 1, page 7) (31,32,33). ROK phosphorylates 
MYPT1 at threonine695, serine849 and threonine850 (chicken isoform 133kDa) (1). Studies 
indicate that phosphorylation of both threonine695 and threonine850 can cause inhibition of 
MYPT1 (34 and reviewed by 1). It is therefore unclear which site is responsible for the 
Ca2+-sensitizing actions of ROK.
Furthermore, there is cross talk between RhoA/ROK mediated Ca2+-sensitization 
and PKC mediated Ca2+-sensitization. ROK has been shown to activate CPI-17 (the 
mediator of PKC activity). Moreover, ROK can directly phosphorylate MLC at the same 
site as MLC kinase. However, studies suggest that ROK mediated inhibition of MLC 
phosphatase is responsible for its Ca2+-sensitizing actions (reviewed by 1).
ROK (a/ II) has been shown to contribute to vascular tone, is upregulated in 
hypertension, and plays a role in cytoskeletal reorganization such as stress fiber 
formation (35 reviewed by 1). ROK is known to play a major role in the Ca2+- 
sensitization elicited by a variety of receptor agonists. Interestingly, a recent study 
suggests that ROK inhibition by HA-1077 and Y27632 results in the inhibition K*- 
induced force (36).
II.6 KCl-induced Calcium Sensitizaton
K+-stimulation (KC1) of smooth muscle causes depolarization of the cell
membrane. This results in opening of voltage-gated Ca2+ channels and an increase in
2+[Ca ]; and muscle contraction. Therefore, KC1 is often used to induce contractile protein 
activation independently of G protein-coupled receptor activation. Moreover, an increase 
in [Ca2+]i is therefore a component o f both K+-depolarization-induced contraction and G 
protein-coupled receptor-elicited contraction.
1
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The degree of Ca -sensitization produced by a particular stimulus is based on the
steepness of the resulting force-[Ca2+]i relationship as compared to that produced upon 
stimulation with KC1 (reviewed by 37). However, Yangisawa and Okada proposed that 
KCl itself can produce an increase in the Ca2+-sensitivity of arteries (38). A very recent 
study also suggests that ROK plays a role in the sustained phase of KCl-induced 
contractions (36).
This hypothesis is supported by work from our laboratory showing that KCl- 
induced contraction can be desensitized following an episode of maximal receptor 
activation, termed non-neuronal cell memory (39,40). This means that if  arteries are 
contracted with a high concentration of an a-adrenergic agonist, the force (but not 
calcium) produced in a subsequent KCl contraction is inhibited when compared to KCl 
contractions in control arteries (that had not been previously contracted). This Ca2+- 
desensitization suggests that the arteries retain a “memory” of the previous receptor 
activation, hence the name non-neuronal cell memory. Though the signaling pathway 
responsibly for non-neuronal call memory remains to be determined, our laboratory also
'74-showed that the degree of Ca -sensitivity for both KCl and receptor agonists (the degree
'y I
of force produced for a given [Ca ]j), is dependent on the history o f receptor activation 
(41). The finding that both G protein-coupled receptor-elicited contractions and KCl 
contractions can be desensitized could suggest a common pathway for Ca2+-sensitization.
Furthermore, treatment of arteries with selective ROK inhibitors results in a 
reduction o f KCl-induced force and MLC phosphorylation without a reduction in [Ca2+]; 
that mimics the desensitized KCl response produced with non-neuronal cell memory.
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These data support a role for ROK activation in KCl-induced contraction and suggest that 
inhibition of ROK activation could play a role in non-neuronal cell memory.
KCl contractions consist of a rapid rise in force peaking in -15 seconds, termed 
the peak phase, and a slower rise to plateau (-3.5 min.), termed the tonic phase. Data 
from our laboratory indicate that the tonic phase o f KCl-induced force is inhibited by the 
ROK inhibitor Y-27632 without causing an inhibition of intracellular Ca2+, suggesting 
that ROK-induced Ca2+-sensitization plays a role in the maintenance of force elicited by 
KCl in vascular smooth muscle. The precise signaling mechanisms involved in KCl- 
induced stimulation of vascular smooth muscle have not been fully resolved.
Ca2+-sensitization involves the coordination of complex signal transduction events 
from the plasma membrane to the contractile apparatus. Receptor agonist stimulation that 
causes Ca2+-sensitization has been shown to result in a redistribution of signaling 
molecules to the cell membrane (42). Although KCl appears to cause Ca2+-sensitization, 
whether KCl-induced contractions result in a recruitment of signaling molecules to the 
plasma membrane of smooth muscle cells remains to be determined.
II.7 Cross talk involving Cyclic Nucleotides
Recent studies suggest that there is cross talk between the cyclic nucleotides, their 
respective protein kinases and the signaling pathways governing Ca2+-sensitization and 
Ca2+-desensitization (reviewed by 43). Smooth muscle relaxation can be achieved in 
two ways; one way is by removal of the contractile stimulus which is called passive 
relaxation. Active relaxation, however is due to the actions of cAMP-dependent protein 
kinase (PKA) and cGMP-dependent protein kinase (PKG). Studies indicate that cGMP 
mediates the relaxing effects of atrial natriuretic peptide and nitric oxide (NO). PKG
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relaxation involves an inhibition of PLC activation, IP3 production and intracellular 
calcium mobilization (reviewed by 43).
Furthermore, PKG is known to cause Ca2+ desensitization by dephosphorylation 
of myosin light chains (44,45,46,47). Studies suggest that G protein-coupled receptors, 
PLC and MLC kinase are substrates for PKA and PKG. Additionally, PKG acting 
downstream of cGMP has been shown to inhibit RhoA-dependent Ca2+-sensitization (48).
74-One study suggests that PKG could participate in Ca -desensitization by 
phosphorylating active RhoA. PKG phosphorylation of RhoA results in its removal from 
the membrane, increasing its interaction with RhoGDI and stabilizing it in the inactive 
form (49). Another study suggests that ROK is a substrate for PKG (22). Though the role 
o f cyclic nucleotides in smooth muscle contraction is complex and not fully understood 
there is evidence of cross talk between cyclic nucleotide dependent protein kinases and 
Ca2+-sensitization.





Caveolae are invaginations of the plasma membrane found in many cell types, 
including smooth muscle cells, hypothesized to participate in clatherin-independent 
endocytosis, cholesterol transport and calcium signaling (50,51,52,53 and reviewed by 
54). Though historically studied as transporters o f molecules across endothelial cell 
membranes, caveolae now are being viewed as a multifunctional membrane system. The 
name caveolae intracellularis (little caves) was proposed by Yamada in 1995 to describe 
“a small pocket... communicating with the outside of the cell” in gallbladder cells.
Palade described similar structures in endothelial cells, but because he observed them 
shuttling molecules in the cells, he referred to them as plasmalemmal vesicles (55).
Other studies supported Palade’s hypothesis, that these were endocytic vesicles, but little 
work was done to determine the role of these structures in other cell types. The recent 
discovery of the integral caveolar proteins, caveolin, have renewed interest in caveolar 
function (56). Current caveolae research focuses on the compartmentalization of signal 
transduction molecules, and the idea that caveolin acts as a scaffold for signaling 
pathways by coordinating extracellular stimuli and intracellular effectors (57).
Caveolae can have a variety of morphological characteristics including a tubular, 
vesicular or flat shape and can be either open or closed at the cell surface. In smooth 
muscle, caveolae are relatively static structures and usually appear as singular 
invaginations in the cell membrane. Caveolae are 50-90 nm concavities along the 
longitudinal axis of smooth muscle cells interspersed with dense bodies (57).
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Biochemical characterization includes resistance to Triton X-100 solubilization at 4°C, a 
light buoyant density and enrichment of cholesterol, glycosphingolipids, sphingomyelin, 
and glycoslyphosphatidlyinositol-anchored protein (54).
111.2 Caveolins
At least four mammalian isoforms of caveolin, caveolin-la, -ip , -2 and -3 
(22kDa) have been identified. Studies suggest that there is ubiquitous expression of 
each caveolin isoform in smooth muscle, specifically caveolin-1 and -3 are found through 
the arterial vasculature. Moreover, caveolin assumes a primarily plasma membrane 
distribution in smooth muscle cells (57). Caveolin isoforms interact to form homo- and 
hetero-oligomers that are stabilized by and require cholesterol for insertion into lipid 
membranes (reviewed by 58). A hydrophobic domain of 33-amino acids (residues 102- 
134) anchors caveolin to the cell membrane such that both the amino and carboxy 
terminals of caveolin are free in the cytosol (53). An N-terminal cytoplasmic region of 
caveolin- 1 (residues 61-101) directs the interaction of caveolins to form hetero- and 
homo-oligomers (58). Within this region there is a “scaffolding domain” (residues 82- 
101) that is critical for the regulatory interactions of caveolin (59). The C-terminal 
domain (residues 135-178) acts as a bridge and allows oligomers of caveolin to interact 
with one another (58).
111.3 Caveolae in Signal Transduction
The caveolin scaffolding domain is necessary for the regulatory interaction of 
caveolin with many signal transduction molecules. Studies using the caveolin scaffolding 
domain have led to the identification of amino acid motifs common to many signaling 
molecules. Motifs containing TXTXXXX'T and TXXXXTXXT where T  = is an
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aromatic amino acid have been found in many molecules suggested to interact with or 
bind to caveolin (57). These motifs have been found in the switch 1 region of RhoA 
(residues 34-42), the catalytic domain of ROK (residues 151-159 and 164-181) and the 
catalytic domain of PKC-a (residues 522-528) (57).
Recent studies have shown caveolae to contain multiple receptors including the p- 
adrenergic, inositol trisphosphate (IP3), muscarinic (M2), endothelin and epidermal 
growth factor (EGF) receptors. Caveolae also contain numerous signal transduction 
molecules including G-protein a  and p subunits, Src-family tyrosine kinases, protein 
kinase C (PKC) isoforms, Ras, calmodulin, and effectors such as mitogen activated 
protein (MAP) kinase, endothelial nitric oxide synthase (eNOS), and adenylyl cyclase
■j,
(53). L-type Ca channels, calreticulin and calsequestrin were found in caveolae- 
enriched membranes which suggests a role for caveolae in smooth muscle Ca2+ handling 
(60).
Studies involving the cytoplasmic delivery of a peptide encoding the scaffolding 
domain result in functional inactivation of G-protein a  subunits, EGFR and PKC, thereby 
suggesting a role for caveolin as a general kinase inhibitor. Other studies indicate that 
caveolin does not inactivate Ha-Ras which suggests a role for caveolae as a site for the 
coordination of activated proteins in some signaling cascades. Some comparisons have 
been made o f the caveolin- 1 scaffolding domain to other modular protein domains, such 
as the plekstrin-homology domain. Therefore, there is a general hypothesis that caveolin 
acts as “molecular Velcro to nucleate the formation of signal transduction complexes” 
(58).
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Receptor agonist stimulation that causes Ca2+-sensitization has been shown to 
result in a redistribution of receptors for contractile agonists to caveolae (61).
Specifically, muscarinic stimulation of isolated smooth muscle cells resulted in 
significant redistribution of ROK, RhoA and PKC-a to the cell periphery (62). 
Furthermore, the introduction of a peptide corresponding to the scaffolding domain of 
caveolin-1, into the cytosol of smooth muscle cells, inhibits the translocation of RhoA 
and PKC elicited by receptor agonist stimulation (62). These data suggest that caveolae, 
via the scaffolding actions of caveolin-1, could play a role in coordinating the signals 
leading from receptor agonist stimulation to Ca2+-sensitization.
III.4 Caveolae Disruption
It has been shown that cholesterol is necessary for invagination and maintenance 
of caveolae, but a recent study shows that both microtubules and actin filaments also play 
a role in regulating the caveolar membrane system (63). The caveolae of cells incubated 
with cytochalasin D, which partially disassembles actin filaments, moved from a 
membranous distribution to an accumulation in the center of the cell. Interestingly, cells 
incubated with nocodazole, which depolymerizes microtubules, showed linear arrays of 
caveolae at the cell surface (63). These data could suggest different roles for actin 
filaments and microtubules in caveolar maintenance.
Furthermore okadaic acid, a protein phosphatase inhibitor, causes internalization 
of caveolae as determined by a decease in the number of invaginations and an 
intracellular accumulation of vesicles (64,54). This internalization was inhibited by 
staurosporine, a kinase inhibitor, suggesting that kinase activity may also be necessary to 
maintain the population of caveolae at the cell membrane (64). Studies suggest that the
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membranous location of caveolae is necessary for it to coordinate signals between the 
extracellular space and the intracellular environment (62), but the specific effects of 
caveolar internalization on ROK-mediated Ca2+-sensitization are not known.
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CHAPTER IV 
CONFOCAL MICROSCOPY
IV.l Theory and Uses of Confocal Microscopy
An increase in the use of fluorescent microscopy in contemporary biology has 
revealed the limitations of wide-field (conventional) light microscopy. Light emitted or 
scattered by objects out of the plane of focus blur the image. One advance that can 
partially overcome the problems of conventional fluorescence microscopy is digital 
deconvolution software which can mathematically remove this out o f plane light to 
sharpen an image. An alternative solution involves the use of confocal microscopy.
The light from a point source, which, in the case of laser scanning confocal 
microscopy (LSM) is a laser, is projected onto an object in the plane o f interest. Light 
(fluorescence) from the focal plane is projected onto a variable pinhole diaphragm 
(which, for these studies, was set at 0.5pm). This light passes through the same objective 
used for focusing and then through a tube lens. Therefore, the focused spot on the 
specimen and the pinhole are at optically conjugate points. Essentially no light, except 
that coming from the plane of interest in the specimen, can pass through the pinhole and 
reach the detector. This virtually eliminates the blurring effect of out o f plane light seen 
in conventional light microscopy.
Two galvanometer mirrors steer the illumination spot over the specimen. The 
fluorescence emitted at the focal plane, and light emitted at planes above and below it, is 
directed onto a main dichroic mirror that separates the emission fluorescence from the 
excitation light. The emission fluorescence is further separated by a series of dichroic 
beam splitters and directed to photomultiplier tubes (PMTs).
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The resolution of the scanned area is variable (but for this project was set at 512 X 
512) and the Z-resolution (0.3 pm), termed the optical section thickness, is determined by 
the microscope software and is based on the numerical aperture o f the objective and the 
pinhole. In the line scanning mode, the lasers scan one line o f the desired focal area, one 
at a time, and the analog signal from the PMTs is converted to a digital signal. This 
results in an almost simultaneous image from multiple laser excitations. Control of the 
focus movement (Z axis) allows for a series of images to be taken and projected as a 
three dimensional image, or analyzed as a stack o f images.
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CHAPTER V 
SPECIFIC AIMS
The goals of this project are to investigate the signaling mechanisms leading from
9+KC1 stimulation to Ca -sensitization in vascular smooth muscle and the mechanisms 
involved in the desensitization of KC1 contractions following an episode of maximal 
receptor activation, termed non-neuronal cell memory. I hypothesize that calcium entry 
through L-type calcium channels and Ca2+/calmodulin activation elicited by KC1 
stimulation leads to translocation of ROK to caveolae and subsequent activation by 
RhoA. I further hypothesize that Ca2+-desensitization in non-neuronal cell memory of 
vascular smooth muscle involves two aspects of the RhoA/ROK signaling pathway; an 
inhibition in ROK translocation to caveolae and an increase in inactive, GDI-bound, 
RhoA possibly due to RhoA phosphorylation and removal from the cell membrane.
Thus, the specific aims of this project are: (1) Determine the mechanism of tonic force 
maintenance in KC1- induced ROK-mediated Ca2+-sensitization of arterial muscle; (2) 
Determine the mechanism by which force maintenance is down regulated in non­
neuronal cell memory.
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CHAPTER VI 
MATERIALS AND METHODS
VI. 1 Tissue Preparation
Tissues were prepared as previously described (65). Femoral and renal arteries 
from adult New Zealand white rabbits were cleaned of adhering tissue and stored in cold 
(0-4°C) physiological saline solution (PSS). The PSS was composed of, in mM, NaCl 
140, KC14.7, MgS0 4 1.2, CaCh 1.6, NaHP0 4 1.2, morpholino-propanesulfonic acid 
(MOPS) 2.0 (adjusted to pH 7.4), Na2ethylenediamine tetraacetic acid (EDTA, to chelate 
heavy metals) 0.02, and D-glucose 5.6. To produce K+-depolarization, KC1 (110 mM) 
was substituted isosmotically for NaCl. High purity water, 17 megaQ distilled and 
deionized, was used throughout. The endothelium of each artery was removed by gently 
rubbing the intimal surface with a metal rod. Tissues were cut into 3-4 mm wide artery 
rings.
Each muscle ring was secured in a tissue bath (Radnoti Glass Technology, Inc., 
Monrovia, CA) between stainless steel wire stirrups attached to a micrometer and 
isometric force transducer for, respectively, length adjustments and isometric force 
measurements (Model 52, Harvard Apparatus, South Natick, MA). Isometric 
contractions were measured as previously described (65). Voltage signals from force 
transducers were digitized (CIO-DAS16F, Computer Boards, Middleboro, MA), and 
visualized on a computer screen as force (g). Data acquisition and analyses were 
accomplished using DasyLab (DasyTec, Amherst, NH) and Microsoft Excel (Microsoft 
Corp.)
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VI.2 Isometric Force
Contractile force (F) was measured as previously described (65). Tissues were 
allowed to equilibrate for 1 hour at 37°C in PSS with aeration. The muscle length for 
which active force was maximum (L0) was determined for each tissue using an 
abbreviated length-tension curve and KC1 (110 mM, substituted isosmotically for NaCl) 
as the stimulus (66,67). For each preloaded tissue, the degree of steady-state force (F) 
produced at L0 by incubation in KC1 for 5-10 minutes was equal to the optimal force for 
muscle contraction (F0), and subsequent contractions were calculated as F/F0. Bay K- 
8644 (0.56-1 pM), a nifedipine analog that increases the open-state probability of L-type
2_j_
voltage-operated Ca channels, was utilized as a contractile agent in some experiments 
(68,69). To produce contraction with Bay K-8644, it was necessary to pre-incubate 
femoral arteries with 7.5 mM KC1, a concentration of KC1 which, alone, did not cause 
contraction. Ionomycin (10 pM), a calcium ionophore, and phenylephrine (PE), an a- 
adrenoreceptor agonist, were also used as contractile agents in some experiments. No 
further length changes were imposed once L0 was established. All tissues, except those 
contracted using PE, were incubated with 1 pM phentolamine (PT) to block potential a- 
adrenergic receptor activation caused by the release of norepinephrine from peri-arterial 
nerves that may occur upon stimulation with KC1.
VI.3 Myosin Light Chain (MLC) Phosphorylation
The degree of MLC phoshorylation was measured as previously described (65). 
Arteries were quick-frozen in an acetone-dry ice slurry, slowly warmed to room 
temperature, dried, weighed, and homogenized in 8M urea, 2% Triton X-100 and 20 mM 
dithiothreitol. Isoelectric variants of the 20 kDa myosin light chains (MLCs) were
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separated by 2-D (IEF/SDS) PAGE followed by Western Blot with visualization using 
colloidal gold staining. The relative amounts of phosphorylated and non-phosphorylated 
MLCs were quantified by digital image analysis (Scion Image, NIH).
VI.4 Intracellular Free Calcium
[Ca2+]i was measured in renal arteries as previously described (65). Arterial rings 
positioned inside a quartz cuvette housed in a fluorometer (Photon Technology 
International, Lawrenceville, NJ) and maintained at 37°C were loaded for 2.5 hours with 
Fura-2 (PE3)/AM (~7.5mM) and Pluronic F-127 (0.01% w/v) (TefLabs, Austin, TX) to 
enhance solubility. Tissues were then washed for 30 minutes in 3 changes of PSS. The 
fluorescence emission at a wavelength of 510 nm was collected for alternating excitations 
at 340 and 380 nm. The [Ca2+]j signals produced during KCl-induced steady-state 
contraction in the absence and presence of Y-27632 were quantified as the fraction of the 
steady-state value produced during the tonic phase of the KC1 contraction used for the L0 
determination, and the minimum signal produced in a Ca2+-free solution containing 5 
mM EGTA plus 10 pM ionomycin, corrected for background fluorescence. The 
background fluorescence was recorded by incubating tissue in a 4 mM MnCb quench 
solution containing 10 pM ionomycin.
VI.5 Tissue and Slide Preparation for Colocalization
The extent of ROK co-localization with caveolin at the plasma membrane of 
femoral artery smooth muscle cells was investigated. Femoral artery rings 3-4 mm long 
were treated as described in “Tissue Preparation”. No difference in ROK colocalization 
to caveolin was identified in stretched (Lo) versus un-stretched (Lz) tissues under basal 
conditions (Lo: 24 ± 2%, Lz: 18 ± 2%, n=3, P>0.05) and when stimulated with KC1 for 30
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sec (Lo: 34 ± 2%, Lz: 34 ± 2%, n=3, P>0.05). Un-stretched artery rings, which were 
technically easier to fix than stretched tissues, were used for all subsequent histological 
studies. Tissues stimulated with KC1 were fixed at 30 sec and 5 min. Colocalization of 
ROK and RhoA with caveolin, RhoA with caveolin, and caveolin with the nucleus in 
KCl-stimulated tissues was compared to that found in tissues not contracted with KC1 
(basal). Tissues stimulated with PE were fixed at 30 sec, 5 and 30 min, following 10 min 
PE washout, and at 30 sec and 5 min of the subsequent KC1 contraction. Colocalization, 
of ROK and RhoA with caveolin, RhoA with caveolin, and caveolin with the nucleus in 
PE-stimulated tissues was compared to that found in tissues not contracted with PE 
(basal).
Tissues were fixed in 100% methanol at -20°C for 5 minutes and then placed in a 
solution containing 5% sucrose for 1 hour. Tissues were rapidly frozen in Optimal 
Cutting Temperature (OCT) frozen tissue embedding medium (VWR Scientific) using a 
histobath (Histobath2 Low Temperature Freezing Bath, Thermo Shandon Inc., Pittsburg, 
PA). Frozen tissues were cut into -18 pm thick sections on a cryostat (Microm HM505E, 
Richard Allan Scientific, Kalamazoo, MI), and each section was placed onto charged 
slides (SuperFrost Plus, Fisher Scientific). Slides were dried for a minimum of 1 hour 
prior to storage at -80°C.
VI.6 Immunohistochemistry
Slides were thawed at room temperature for 30 minutes and washed twice in PSS. 
Small wells were created on each slide using an ImmEdge Pen (Vector Labs,
Burlingame, CA). Tissues were permeabilized and blocked in one step using a solution 
of 0.1% Triton X-100 and 3% normal goat serum (Vector Labs, Burlingame, CA) in PSS.
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The slides were washed twice in PSS and incubated with primary antibodies to ROK 
(anti-rock-2, goat polyclonal, Santa Cruz Biosciences, Inc., Santa Cruz, CA), caveolin 
(anti-caveolin, rabbit polyclonal, BD Biosciences), RhoA (anti-RhoA, mouse 
monoclonal, Santa Cruz Biosciences, Inc., Santa Cruz, CA), or RhoGDI (anti-RhoGDI, 
rabbit polyclonal, Santa Cruz Biosciences, Inc., Santa Cruz, CA) for one hour at an 
optimized dilution of 1:50. The anti-caveolin antibody used in this study does not 
discriminate between the 3 isoforms of caveolin. Slides were washed twice in PSS and 
incubated with fluorophore-conjugated secondary antibodies (Alexa Fluor 488 donkey 
anti-goat, for ROK; Alexa Fluor 594 chicken anti-rabbit, for caveolin and RhoGDI; and 
Alexa Flour 488 donkey anti-mouse, for RhoA; Molecular Probes, Inc., Eugene Oregon) 
for one hour at an optimized dilution of 1:200. For nuclear staining, slides were washed 
twice in PSS and incubated with a nuclear stain (TO-PRO-1 iodide monomeric cyanine 
nucleic acid stain iodide, Molecular Probes, Inc., Eugene Oregon) for 10 minutes at a 
dilution of 1:80,000. Tissue sections were washed a final time and coverslips were 
applied with an anti-fading medium (VectaShield Anti-fading Medium, Vector Labs, 
Burlingame, CA). Slides were viewed and images recorded using a laser scanning 
confocal microscope (Zeiss LSM 510, Carl Zeiss Microscopy, Germany). Each tissue 
section was excited with two lasers, Krypton/Argon (488 nm) and Helium/Neonl (543 
nm), using a rapid line-scanning protocol for excitation, and emission signals were 
collected through, respectively, 505-550 nm band pass and 560 nm long pass emission 
filters and quantified using a photomultiplier tube and proprietary software. For display 
purposes, a composite image was constructed in which, for example, ROK was green, 
caveolin was red and signal overlap (colocalization) was yellow. For RhoA
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colocalization to caveolin, RhoA was green and caveolin was red. For RhoA 
colocalization with RhoAGDI, RhoA was green and RhoGDI was red, and for caveolin 
colocalization to the nucleus, caveolin was red and the nucleus was green.
Approximately 11 images were recorded in the z-dimension, which constituted 
one z-series. Images were taken 0.5 pm apart with a zoom of 2X on a 100X oil 
immersion objective. The pinhole was 0.5 airy units. One slide was randomly selected 
for viewing and analyses from each sectioned artery ring. A minimum of 2 z-series were 
recorded for each slide from different areas of the tissue. Images were exported in an 
uncompressed tagged-image format (tif) file and image analysis was conducted using 
MetaMorph software (Version 4.6r9, Universal Imaging Corporation).
VI.7 Image Analysis and Data Collection
Five consecutive images selected from two different z-series per slide permitted 
10 images to be averaged for each artery ring. MetaMorph software (V4.6r9 Universal 
Imaging Corp.) separated each composite image into two images, one for each laser. The 
software compared the images, pixel by pixel, and determined the percentage overlap of 
the fluorescent signals. For example, in specific aim 1 we tested the hypothesis that KC1 
increased the degree of ROK translocation to caveolae at the plasma membrane, so 
colocalization of the two fluorophores was determined as the percentage overlap of the 
ROK signal onto the caveolin signal. RhoA colocalization with caveolin, RhoA 
colocalization with RhoGDI, and caveolin colocalization with the nucleus were 
determined in the same manner. Colocalization measured for all 10 images was 
averaged using a spreadsheet (Excel, Microsoft Corp.) and considered an n of 1.
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VI.8 Drugs
Nifedipine and trifluoperazine (TFP), okadic acid, phenylephrine and 8br-cGMP 
were from Sigma Corporation. Bay K-8644, Y-27632 and ionomycin were from 
Calbiochem Corporation. HA-1077 and GF-109203X were from Alexis Corporation. 
Nifedipine, Bay K-8644, 8br-cGMP and ionomycin were dissolved in ethanol. Y-27632, 
phenylephrine and okadaic acid were dissolved in water. Ethanol was added at a final 
concentration no greater than 0.1%, a concentration that had no effect on KC1- or Bay K- 
8644-induced contractions or on the degree of ROK co-localization with caveolin.
VI.9 Statistics
The null hypothesis was examined using Students’ t-test (when 2 groups were 
compared) or using a one-way analysis of variance (ANOVA). To determine differences 
between groups following ANOVA, the Student-Neuman-Keuls post-hoc test was used.
In all cases, the null hypothesis was rejected at P<0.05. For each study described, the n 
value was equal to the number o f rabbits from which arteries were taken.




VII. 1 Effect of ROK, PKC, and L-type calcium channel inhibitors on KCl-induced 
force
A KCl-induced contraction (110 mM KC1 substituted isosmotically for NaCl) of 
rabbit femoral and renal artery consisted of a rapid rise in force that reached a maximum 
value within -15 sec (Peak, Fig 2A) followed by a slower rise to a sustained level within 
~3-5 minutes (Tonic; Fig 2A). To determine the effect of ROK inhibition on KCl- 
induced contraction, tissues were exposed to two different ROK inhibitors; Y-27632 (1 
and 3 pM) or HA-1077 (10 pM), then contracted with KC1. Although peak force was not 
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Figure 2. Effects of 
ROK inhibitors, Y- 
27632 (Y; 1 and 3 pM) 
and HA-1077 (HA; 10 
pM), and the PKCn;C 
inhibitor, GF-109203X 
(GF; 1 pM), on peak (B) 
and tonic (C) KCl- 
induced force. Control 
(Con) tissues were not 
exposed to a drug. 
Typical force tracings 
are shown in panel A. 
Data in B and C are 
mean ± SE; n = 3-5; * 
p< 0.05 compared to 
control.
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PKC has been shown to play a role in receptor agonist-induced Ca2+ sensitization, 
so we also investigated the role of PKC in KCl-induced contraction. GF-109203X, when 
used at 1 pM, inhibits conventional and novel isoforms (PKCc,n) of PKC (32,70,71). GF- 
109203X did not inhibit KCl-induced peak or tonic force (Figs 2B and 2C). These data 
suggest that ROK does, but PKCc,n does not, play a role in the maintenance of KCl- 
induced tonic force in rabbit large arteries.
VII.2 Effect of Y-27632 and nifedipine on KCl-induced force and [Ca2+]j
Inhibition of KCl-induced tonic force by Y-27632 could be caused by inhibition 
of ROK, or by inhibition of Ca2+ entry caused by a non-specific effect o f the drug on 
Ca2+channels. We therefore measured the effect of Y-27632 on steady-state increases in 
force and [Ca2+]i produced by KC1. Tissues were loaded with the Ca2+ indicator, fura-2 
(see “Methods”) and contracted with KC1. Y-27632 (1 pM) was added and force and 
[Ca2+]i were allowed to reach a new steady-state. The L-type calcium channel inhibitor, 
nifedipine (10 nM), was subsequently added to completely relax tissues by causing Ca2+ 
channel blockade (Figs 3A and 3C). Y-27632 reduced tonic KCl-induced force by nearly 
40% (Figs 3A and 3B) but did not alter tonic [Ca2+]i (Figs 3C and 3D). Nifedipine 
further reduced tonic force to the basal level (Figs 3A and 3B) and nearly abolished 
[Ca2+]i (Fig 3C and 3D). These data indicate that 1 pM Y-27632 does not block KCl- 
induced calcium entry, and suggest that KC1 induces the activation o f ROK.
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Figure 3. Effect of Y-27632 (1 pM) and nifedipine (10 nM) on KCl-induced force (A & 
B) and [Ca2+]; (C & D). Typical force and calcium tracings are shown in, respectively, A 
& C. Data in B and D are mean ± SE; n=3; * p< 0.05 compared to KCl-induced 
responses.
VII.3 Effect of Y-27632 on KC1-, Bay K-8644-, and ionomycin-induced MLC 
phosphorylation and force
The level of MLC phosphorylation basally was 9% ± 1%, and KCl-induced 
contraction resulted in an increase in MLC phosphorylation to -37% . Y-27632 (1 pM) 
nearly abolished this increase (Fig 4A). We also investigated the effect o f Y-27632 on 
responses produced by an agent that selectively activates L-type Ca2+channels to cause 
Ca2+ entry and contraction. Bay K-8644 (0.56 pM), a nifedipine analog but Ca2+channel 
agonist, produced a slow rise in force that reached a plateau in -20  min. Y-27632 (1 pM)
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nearly abolished Bay K-8644-induced steady-state MLC phosphorylation (Fig 4A) and 
reduced steady-state force by over 70% (Fig 4B). We next examined the ability of Y- 
27632 to inhibit responses produced by the Ca2+ ionophore, ionomycin, an agent that can 
bypass L-type calcium channels to produce contraction by Ca entry or release of 
intracellular Ca2+. Ionomycin (10 pM) produced a rise in force that reached a plateau in 
-6 .5  min. Y-27632 (3 pM) nearly abolished ionomycin-induced MLC phosphorylation
'7-4-(Fig 4A) and force (Fig 4C). The ionophore-dependent transfer of Ca ions into smooth 
muscle cells elicited by ionomycin has been shown to cause membrane depolarization 
and thus force development (72). As seen in Fig 4C, we found that 1 pM nifedipine did 
not inhibit 10 pM ionomycin-induced contraction in rabbit femoral artery.
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Figure 4. Effect of the ROK inhibitor, Y-27632 (1 pM) on KCl-induced, 0.56 pM 
Bay K-8644-induced and 10 pM ionomycin-induced MLC phosphorylation (A) 
and Bay K-8644- and ionomycin-induced force (B and C, respectively). Effect of 1 
pM nifedipine on ionomycin-induced force (C). Control tissues were not exposed 
to a drug. Data are mean ± SE; n~3-5; * p< 0.05 compared to control.
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VII.4 Time dependent effects of Y27632 and nifedipine on KCl-induced force and 
MLC phosphorylation
Basal force and MLC phosphorylation were not affected by either 1 pM Y27632 
or 1 pM nifedipine (Fig 5). Whereas nifedipine nearly abolished the KCl-induced 
increase in force and phosphorylation at 10 seconds and 1 and 5 minutes of contraction, 
Y27632 did not decrease KCl-induced force and phosphorylation at 10 seconds, but did 
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Figure 5. Effect of 1 pM Y- 
27632 and 1 pM nifedipine 
compared to control (no drug 
addition) on KCl-induced 
increases in force (A) and MLC 
phosphorylation (B). Data are 
m ean± SE; n=3-6; * p< 0.05 
compared to control.
Time (min)
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VII.5 Effect of KC1 and Bay K-8644 on ROK colocalization with caveolin at the cell 
periphery
In an image of an unstained femoral artery, captured using a 40X oil immersion 
objective of a laser scanning confocal microscope (see “Methods”), auto-fluorescence 
was evident in the adventitia and intima, shown, respectively, on the upper left and lower 
right comers o f the image of Fig 6A. The media, however, displayed very little auto­
fluorescence, although elastic lamina between layers of smooth muscle cells could be 
seen (Fig 6A). Images at 200X used for fluorescence co-localization measurements in 
this study were taken from areas of the media between elastic lamina rich in vascular 
smooth muscle cells and nearly devoid of auto-fluorescence.
The secondary antibodies used in this study (see “Methods”), when applied alone 
displayed minimal fluorescence when a section of rabbit femoral artery media was 
viewed at 200X between layers of elastic lamina (Fig 6B). However, vascular smooth 
muscle cells were clearly evident in fluorescence confocal images taken from tissues 
labeled with ROK and caveolin primary antibodies such that caveolin appeared red (Fig 
6C) and ROK appeared green (Fig 6D). Caveolin was localized at the cell periphery, as 
expected (Fig 6C), while ROK was distributed throughout the cytosol and at the cell 
periphery (Fig 6D). Figures 6C-E are representative images o f our data showing ROK 
and caveolin staining. Due the secondary antibodies used, in images showing RhoA 
colocalization with caveolin, RhoA appeared as green and caveolin appeared as red. In 
images showing colocalization of RhoA to RhoGDI, RhoA appeared as green and 
RhoGDI appeared as red, and in images showing caveolin colocalization with the 
nucleus, caveolin appeared as red and the nucleus appeared as green.
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C.
Figure 6. Laser scanning confocal images o f rabbit femoral artery. A) unstained 40X 
image showing auto-fluorescence in adventitia (upper left) and intima (lower right). B) 
200X image labeled with Alexa Fluor 488 donkey anti-goat, and Alexa Fluor 594 chicken 
anti -rabbit 2° antibodies, showing minimal non-specific labeling. C-E) 200X image o f an 
artery stimulated for 30” with KC1 double-labeled with anti-ROKa goat polyclonal 
antibody (plus Alexa Fluor 488 donkey anti-goat 2°) and anti -caveolin rabbit polyclonal 
antibody (plus Alexa Fluor 594 chicken anti-rabbit 2°), as described in “Methods”. Image 
E) is a composite o f images C) showing caveolin (red) staining only and D) showing 
ROK (green) staining only. The yellow color in “E” represents ROK colocalization with 
caveolin.
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In un-contracted (basal) tissues -18%  of ROK was colocalized with caveolin at 
the cell periphery (quantified using MetaMorph software as described in “Methods”, and 
visualized graphically as yellow in Fig 6E). The amount of ROK co-localized with 
caveolin at the cell periphery nearly doubled at 30” of KC1 stimulation (Fig 6A). At 5 
min of a KC1 stimulus, the amount o f ROK colocalized with caveolin at the cell periphery 
had returned to the basal level (Fig 6A).
Thus, -16%  of ROK translocated to caveolae at the smooth muscle cell 
membrane early during development of a KCl-induced contraction (30”) and prior to 
development of the slower component of a KCl-induced contraction (tonic phase) that 
was inhibited by the ROK inhibitor, Y-27632 (see Figs 2 and 5). Moreover, an equal 
amount of ROK (-16%) returned to the cytosol during the tonic phase of contraction. 
These data together indicate that ROK translocation to the periphery o f the cell preceded 
the tonic phase of a KCl-induced contraction but that sustained ROK translocation was 
not necessary for the maintenance o f tonic contraction.
The calcium channel agonist, Bay K-8644, like KC1, produced a similar 
movement o f ROK to the periphery of vascular smooth muscle cells. The addition of 7.5 
mM KC1 10 min prior to addition of Bay K-8644, which was needed for Bay K-8644- 
induced contraction in rabbit femoral and renal arteries, did not produce a contraction, 
nor did it increase ROK translocation from the cytosol to periphery (basal, Fig 7B, 
compared to basal in the absence o f 7.5 mM KC1, shown in Fig 7A). However, at 30 sec 
of stimulation with Bay K-8644, -31%  of ROK was colocalized with caveolin at the cell 
periphery (Fig 7B). At 5 min, the percentage of ROK colocalized with caveolin returned 
to the basal level (Fig 7B).
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Figure 7. Percent colocalization of ROK with caveolin at the cell periphery in 
rabbit femoral artery at 30 sec (30”) and 5 min (5’) of stimulation with KC1 (A) 
and 0.56 pM Bay K-8644 (B). Tissues stimulated with Bay K-8644 were exposed 
to 7.5 mM KC1, a concentration that alone, did not cause contraction. Basal tissues 
were not stimulated. Data are mean ± SE; n=3; * p< 0.05 compared to basal.
VII.6 Effect of nifedipine and trifluoperazine (TFP) on the ability of KC1, Bay K- 
8644 and ionomycin to cause increased ROK colocalization with caveolin at the cell 
periphery
Our data show that stimuli that increase [Ca2+]j also cause an increase in the 
degree o f ROK translocation to the cell periphery, suggesting that increased [Ca2+]j 
causes ROK translocation to caveolin. Thus, we examined whether inhibition of L-type 
voltage-operated Ca2+ channels and Ca2+/calmodulin would inhibit KCl-induced ROK 
translocation to the cell periphery. Nifedipine (Fig 8A) abolished the increase in 
colocalization o f ROK with caveolin at the cell periphery at 30 sec of stimulation with 
KC1, suggesting that calcium entry through L-type calcium channels plays a role in KC1-
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induced translocation of ROK. TFP, a Ca2+/calmodulin inhibitor (Fig 8B), also abolished 
the increase in colocalization of ROK with caveolin at 30 sec o f stimulation with KC1. 
Y-27632 did not inhibit ROK translocation (Fig 8C), suggesting that ROK activation was 
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Figure 8. Effect o f nifedipine (1 pM; A), trifluoperazine (TFP, 100 pM; B) and Y-27632 
(1 pM; C) on percent colocalization of ROK with caveolin at the cell periphery in rabbit 
femoral artery stimulated for 30 sec (30”) and 5 min (5’) with KC1. Basal tissues were not 
stimulated. Data are mean ± SE; n=3; * p< 0.05 compared to basal.
Although 1 pM nifedipine inhibited both KCl-induced (Fig 8A) and Bay K-8644- 
induced (Fig 9) increases in ROK translocation to caveolin at 30 sec, nifedipine did not 
inhibit ionomycin-induced ROK translocation (Fig 9). These data, along with our finding 
that nifedipine did not inhibit ionomycin-induced early force development (Fig 4C) 
suggest that nifedipine-insensitive Ca2+ translocation or release of intracellular Ca2+ by 
ionomycin caused ROK translocation to caveolin. TFP inhibited Bay K-8644 and
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ionomycin induced ROK translocation to caveolin (Fig 9), supporting a role for Ca2+- 
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Figure 9. Effect of 1 pM nifedipine and 100 pM trifluoperazine (TFP) on the ability of 1 
pM Bay K-8644 and 10 pM ionomycin to increase ROK colocalization to caveolae at 30 
sec of stimulation. Data are mean ± SE; n=3; * p< 0.05 compared to basal.
V II.7  Nifedipine concentration-dependent inhibition of R O K  translocation to 
caveolae
If 1 pM nifedipine inhibited KCl-induced ROK translocation to caveolin because 
of inhibition o f Ca2+ entry, then lower nifedipine concentrations that partially inhibit Ca2+ 
entry should cause partial inhibition of ROK translocation. This was found to be the case. 
Whereas 1 pM abolished the increase in ROK translocation produced by KC1 at 30 sec 
(Fig 10, and see Fig 8 A), lower nifedipine concentrations known to cause partial
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inhibition o f calcium entry and contraction (69) caused only partial inhibition of KCl- 
induced ROK translocation to caveolin (Fig 10).
40
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Figure.10. Concentration-dependent inhibition of ROK translocation to caveolae by the 
calcium channel blocker, nifedipine. Data are mean ± SE; n=4; * p< 0.05 compared to 
basal. 30 sec KC1 data in the absence of nifedipine is taken from Fig 6A.
VII.8 Effect of KC1 on RhoA translocation to caveolae
Others have shown that upon stimulation with receptor agonists there is a 
translocation of RhoA to the cell periphery. These studies did not quantify RhoA 
movement as colocalization with caveolae, but as increase in RhoA in the cortical region 
of the cell (42,21). We determined that in un-contracted (basal) tissues -30%  of RhoA 
was colocalized with caveolin at the cell periphery, and there was no increase in RhoA 
colocalization with caveolin at 30” of KC1 stimulation (Fig 11). These data suggest a 
new model for interaction between RhoA and ROK in which the amount o f RhoA at the
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Figure 11. Percent 
colocalization of RhoA 
with caveolin at the cell 
periphery in rabbit 
femoral artery at 30 sec 
of stimulation with KCI. 
Basal tissues were not 
stimulated. Data are 
mean ± SE; n=3; * p< 
0.05 compared to basal.
VII.9 Effect of non-neuronal cell memory on ROK and RhoA translocation to 
caveolae
Previous data from our laboratory shows that rabbit femoral artery muscle can 
retain a memory of previous receptor activation, called non-neuronal cell memory. 
Femoral arteries were contracted with a maximum concentration (10'5M) of the a- 
adrenoreceptor agonist phenylephrine (PE) and relaxed by 10 minute PE washout, which 
is sufficient to completely relax the artery. Tonic force and MLC phosphorylation in a 
subsequent KCI contraction were reduced by 60 % when compared to tissues not 
previously contracted with PE, whereas [Ca2+]; was unchanged (39,40).
In the present study, the colocalization of ROK and RhoA to caveolin was 
investigated during PE stimulation and the subsequent KCI contraction to investigate the 
postreceptor signaling mechanisms governing non-neuronal cell memory. ROK
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colocalization to caveolin doubles, from basal levels, at 30 seconds of PE contraction 
(Fig 12A) and remains greater than the basal colocalization level at 5 and 30 minutes of 
PE contraction. Upon PE washout and muscle relaxation, the level of ROK 
colocalization to caveolin was reduced to the prestimulus basal level. However, unlike 
tissues that were not pretreated with PE that display robust increases in ROK 
translocation to caveolin at 30 sec of KCI stimulation, those pretreated with PE showed 
no increase in ROK translocation to caveolin when subsequently stimulated with KCI for 
30 sec (Fig 12A).
These data support our hypothesis that tonic force maintenance requires ROK 
translocation to caveolin, and suggest that one reason PE-pretreatment inhibits KCl- 
induced force maintenance is that PE-pretreatment inhibits stimulus-induced increases in 
ROK translocation to caveolae.
We found that under basal conditions, a high percentage (-30% ) of the principal 
cell activator of ROK, RhoA, is colocalized to caveolin at the cell periphery (Fig 11). 
Thus, we also investigated the effect of PE-pretreatment on RhoA colocalization to 
caveolin. Interestingly, RhoA colocalization to caveolin was decreased below the basal 
level at 30 minutes of PE contraction and remained below the basal level during the 
subsequent KCI contraction (Fig 12B). These data suggest that another mechanism of 
desensitization (reduced force maintenance without reduced increases in [Ca2+]i) in non­
neuronal cell memory involves decrease in RhoA available for activation o f ROK at 
caveolae.
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Figure 12. Percentage 
colocalization of ROK 
(A) and RhoA (B) to 
caveolin in non-neuronal 
cell memory. Arteries 
were contracted with 10 
[xM phenylephrine for 
30 minutes, and the 
washed out for 10 
minutes in the presence 
of the a-adrenoreceptor 
antagonist phentolamine 
(1 pM). The arteries 
were subsequently 
contracted in KCI for 5 
minutes. Tissues were 
fixed each time point for 
analysis as described in 
(‘Methods’). Data are 
mean ± SE; n=4; * p< 
0.05 compared to basal.
VII.10 Effect of lower PE concentration and longer washout period on inhibition of 
ROK translocation in non-neuronal cell memory
Our laboratory has shown that the degree of downregulation in non-neuronal 
memory depends on the concentration of PE used during the pretreatment episode, the 
duration of the receptor activation and the duration o f the washout period (41). Whereas
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lOpM PE pretreatment caused desensitization of both KCI- and histamine-induced 
contractions, an EC50 concentration of PE (0.1 pM) did not induce desensitization, non­
neuronal cell memory, when tissues were subsequently stimulated to contract. The 
degree o f desensitization produced after pretreatment with lOpM PE was significantly 
weaker in tissues following a PE washout of 2 hours than those washed for 10 minutes 
(41). I therefore tested the hypothesis that pretreatment with 0.1 pM PE or a 2 hour 
washout following 10 pM PE pretreatment would not inhibit the colocalization of ROK 
to caveolin in a subsequent KCI contraction. Following pretreatment with 0.1 pM PE, 
ROK colocalization to caveolin at 30 seconds of KCI contraction nearly doubled from 
basal levels (Fig 13 A). Also, ROK colocalization to caveolin nearly doubled if the PE 
washout time is increased to 2 hours (Fig 13B).
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Figure 13. Percentage colocalization of ROK to caveolin in non-neuronal cell memory 
with lower concentration of PE (0.1 pM; A) and increased washout time (2 hours; B). 
Data are mean ± SE; n=3; * p< 0.05 compared to basal.
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Therefore, KCI produced the same degree of ROK translocation to caveolin at 30 
seconds when compared to arteries that were not pretreated if the concentration of the PE 
stimulus was decreased from 10 pM to 0.1 pM, and if the washout time was increased 
from 10 minutes to 2 hours. These data offer further evidence that non-neuronal cell 
memory involves the RhoA /ROK signaling pathway.
VII. 11 Effect of 8br-cGMP treatment on ROK and RhoA translocation to caveolin
Our laboratory previously reported that there is a basal level of vasodilator- 
stimulated phosphoprotein [VASP(Ser )] phosphorylation in intact femoral arteries, 
which is a measure of PKG activity. VASP phosphorylation is abolished by 1H- 
[l,2,4]oxadiazolo[4,3-a]quinoxalin-l-one (ODQ) and increased in the presence of a cell- 
permeable activator o f PKG, 8br-cGMP (73). Treatment of arteries with 8br-cGMP also 
resulted in a decrease in active force but not [Ca2+]i to subsequent histamine and Bay K- 
8644 contractions in a manner similar to non-neuronal cell memory. The effect of 100 
pM 8br-cGMP treatment on ROK and RhoA colocalization to caveolin was determined 
to investigate the role o f PKG activity in non-neuronal cell memory.
While not reducing the degree o f basal ROK colocalized with caveolin, 8br- 
cGMP prevented the increase in ROK colocalization to caveolin produced at 30 seconds 
by KCI and PE (Fig 14A) compared to untreated arteries (Fig 7A). Moreover, the level 
o f RhoA colocalization to caveolin basally was decreased from -28%  to -18%  for basal 
arteries (Fig 14B).






















Figure 14. Colocalization of ROK (A) and RhoA (B) to caveolin in KCI- and PE- 
stimulated tissues pretreated with 100 pM 8br-cGMP. Data are mean ± SE; n=3-6; * p< 
0.05 compared to basal.
We found that neither KCI nor PE produced an increase in RhoA colocalization to 
caveolin, from basal levels, at 30 sec of stimulation (Figs 11 and 12B), and in the 
presence of 8br-cGMP, neither KCI nor PE produced an increase from the low level 
induced by 8br-cGMP alone. These data are similar to that determined following 
pretreatment with 10 pM PE (Figs 12A&B), and could suggest either a common 
mechanism for desensitization of the KCI response through convergence o f signaling 
pathways, or that PE-induced increases in PKG activity caused non-neuronal cell 
memory.
VII.12 Effect of non-neuronal cell memory on RhoA colocalization to RhoGDI
RhoA cycles between the inactive GDP-bound form and the active GTP-bound 
form via guanine nucleotide exchange and GTP hydrolysis. The protein RhoGDI retains 
RhoA in an inactive state by inhibiting guanine nucleotide exchange and hydrolysis.
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Moreover, RhoGDI extracts Rho proteins from the cell membrane maintaining them as 
cytosolic and inactive proteins (74). We found that both treatment with 8br-cGMP and 
30 minutes of 10 pM PE pretreatment reduced the basal amount of RhoA colocalized to 
caveolin (Fig 14B and 12B, respectively). A possible explanation for this reduction in 
basal RhoA at the cell periphery is that these stimuli increase the amount of RhoA bound 
to RhoGDI in the cytosol.
We tested this hypothesis and found that there was an increase in the 
colocalization o f RhoA with RhoGDI at 30 minutes of PE contraction and at 30 seconds 
of a subsequent KCI contraction (Fig 15 A). These data suggest that an increase in 
inactive, GDI-bound RhoA is involved in non-neuronal cell memory. Furthermore, there 
is an increase in the colocalization of RhoA with RhoGDI in tissues pretreated with 8BR- 
cGMP (Fig 15B).
Taken together these data suggest that a common component in the mechanism 
for downregulation in both non-neuronal cell memory (PE pretreatment) and arteries 
pretreated with 8br-cGMP is an inhibition of RhoA activity by the binding of RhoGDI to 
RhoA. Removal of active RhoA from the membrane, as determined by a decrease in 
RhoA colocalization to caveolin, in PE and 8br-cGMP pretreated arteries further supports 
this idea (Figs 12B and 14B).
Recent studies indicate that 8br-cGMP, via the actions o f PKG, causes Ca2+- 
desensitization by dephosphorylation of myosin light chains (44,45). Recent data also 
suggest that PKG phosphorylates RhoA on Ser188 resulting in its removal from the 
membrane and increasing its interaction with RhoGDI (49). Our data demonstrate a 
reduction in ROK translocation and reduced RhoA activity by increasing the proportion
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of RhoA in the cytosolic, RhoGDI-bound form, and therefore support the hypothesis that
94-PKG causes Ca -desensitization.
-A. Non-neuronal cell memory - RhoA to GDI
10uM PE
10 minute washout 
with 1pM phentolamine
B. Colocalizaton of RhoA to GDI Figure 15. Colocalization of 
RhoA to RhoGDI in non-neuronal 
cell memory (A) and in arteries 
treated with 100 jxM 8br-cGMP 
(B). Data are mean ± SE; n=3; * 
p< 0.05 compared to basal.
8br cGMP
VII.13 Effect of okadaic acid on KCl-induced force and [Ca2+]j
Our laboratory has also shown desensitization of femoral arteries to KCl-induced 
increases in force and [Ca2+]i by pretreatment with known PP1 inhibitors, NaF and 
okadaic acid (OA) (75). The mechanism of PP1 inhibitor desensitization is not known
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but has been hypothesized to involve desensitization of L-type calcium channels or 
proteins associated with the channels (75,76). Others have shown that okadaic acid 
induces the removal of caveolae from the cell surface and that caveolae internalization is 
a kinase dependent phenomenon (64). It has been reported that translocation of ROK and 
RhoA to the cell membrane is necessary for their Ca2+ sensitizing actions which could 
suggest that an intact caveolar membrane at the cell membrane is also necessary for the 
coordination of RhoA/ROK signaling.
We found that by 45 minutes, 1 pM okadaic acid abolished the force elicited by 
KCI (Fig 16A) and greatly reduced the degree of KCl-induced [Ca2+]i (16B). Given the 
report that okadaic acid leads to reductions in the amount of peripheral caveolae available 
for signalosome activity (64), these data suggest that intact caveolae are necessary for 
KCl-induced force maintenance. The data also suggest a role for kinase-mediated 
caveolar disruption in desensitization of the KCI response.
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Figure 16. Effect of 1 pM okadaic acid on KCl-induced force (A) and [Ca2+]i (B). Data 
are mean ± SE; n=3; * p< 0.05 compared to basal (A) and to 15’(B).
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VII.14 Effect of okadaic acid and sodium fluoride on KCl-induced ROK 
colocalization with caveolin at the cell periphery
To investigate the effect of caveolar disruption on the RhoA/ROK signaling 
pathway, arteries were treated with either 10 mM NaF or 1 pM OA, and ROK 
colocalization to caveolin was determined. The colocalization of ROK to caveolin at 30 
seconds of KCI contraction was abolished by treatment with either NaF or OA (Fig 17A).
w
Figure 17. Effect of 1 pM okadaic acid and 10 mM NaF on KCl-induced ROK 
colocalization with caveolin at the cell periphery (A) and colocalization of caveolin with 
the nucleus (B). Data are mean ± SE; n=3; * p< 0.05 compared to basal.
To qualify the degree of caveolar movement away from the peripheral sites 
induced by treatment with either NaF or OA, we measured the degree of colocalization of 
caveolin with the nucleus. Under basal conditions, less that 5% of total cellular caveolin 
colocalizes with the nuclear compartment, and following exposure to the protein 
phosphatase inhibitors, OA and NaF, this percentage doubled (17B). This increase in
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nuclear caveolin supports the contention that OA and NaF decrease the amount of 
peripheral caveolae by causing caveolar internalization (Fig 17B).
VII.15 Effect of actin filament and microtubule disruption on KCl-induced ROK 
colocalization with caveolin at the cell periphery
Recent studies suggest that depolymerization of microtubules causes non­
receptor-dependent contraction of vascular smooth muscle (77), and others report that 
contractions caused by microtubule depolymerization involve ROK-dependent Ca2+- 
sensitization (78,79). It has been hypothesized there is dual control o f caveolae by actin 
filaments and microtubules such that microtubule disruption results in an increase in 
invagination depth of caveolae and actin filament disruption results in a decrease in 
transportation between the endoplasmic reticulum and caveolae (63). To determine the 
role of microtubules and actin filaments in KCl-induced ROK translocation, we 
determined ROK colocalization with caveolae in the presence of the microtubule 
depolymerizing agents nocodazole and colchicine and the actin filament disrupting agent 
cytochalasin D. Treatment with cytochalasin D (1 pM) reduced the KCl-induced increase 
in ROK colocalization to caveolin by -50% . Treatment with colchicine (10 pM) did not 
affect ROK translocation, but nocodazole (10 pM) inhibited ROK colocalization with 
caveolae by -25% . These data suggest that both actin filaments and microtubules play a 
role in ROK signaling, and these data support the hypotheses of others that caveolae and 
thus caveolar signaling is under the dual control of actin filaments and microtubules (63). 
Specifically, our results indicating that cytochalasin D causes a -50%  reduction in ROK 
translocation, support the hypothesis that transport to caveolae requires intact actin 
filaments.
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Figure 18. Colocalization of 
ROK with caveolin in arteries 
treated with cytochalasin D 
(cytoD; 1 pM), nocodazole 
(Noc; 10 pM), and colchicine 
(colch; 10 pM). Data are 
mean ± SE; n=3; * p< 0.05 
compared to KCI at 30”.
VII.16 Effect of 8br-cGMP and PE pretreatment on KCl-induced caveolin 
colocalization with the nucleus
To investigate the role of caveolar internalization in non-neuronal cell memory 
and 8br-cGMP-induced desensitization o f the KCI responses, arteries were pretreated 
with either lOOpM 8br-cGMP or lOpM PE for 30 minutes. The colocalization of 
caveolin to the nucleus more than doubled following pretreatment with 8br-cGMP, but 
PE pretreatment for 30 minutes did not cause a significant increase in caveolar 
colocalization with the nucleus.
These data suggest that non-neuronal cell memory (PE pretreatment) and 8br- 
cGMP pretreatment do not operate by entirely identical mechanisms to cause 
desensitization o f a subsequent KCI contraction, but do share two common features. First 
is an inhibition o f ROK colocalization to caveolae, and second is a decrease of RhoA at 
caveolae as determined by both a decrease in RhoA colocalization to caveolae and an 
increase in RhoA colocalization with RhoG DI.





























cavolin to nucleus in 
100 jaM 8br-cGMP and 
10 pM PE pretreated 
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Vascular smooth muscle contraction is governed by an increase in [Ca2+]; and by 
Ca2+-sensitization (reviewed by 37). Whereas the Ca2+/calmodulin-dependent activation 
of MLC kinase is a well understood mechanism for causing smooth muscle contraction, 
the precise signaling mechanisms involved in Ca2+-sensitization have not been entirely 
elucidated. The clinical relevance of study in this field is that many pathophysiological 
conditions, including hypertension and vasospasm of the coronary and cerebral vessels, 
have been linked to an abnormal state of vascular smooth muscle contraction and an
9+overactivity of pathways leading to Ca -sensitization.
One hypothesis for Ca2+-sensitization of smooth muscle involves regulation of the 
interaction of actin and myosin by thin filament associated proteins. Though there is 
evidence that supports this hypothesis in some tissues, the majority o f proposed
9 -4- • ■ ■ • •
mechanisms for Ca -sensitization involve regulation of MLC phosphatase (reviewed by
9+20, 22). Several studies indicate that the Ca -sensitization elicited by receptor agonists 
involves inhibition of the myosin targeting subunit of MLC phosphatase (MYPT1) via 
the actions of PKC and RhoA. PKC activates PKC potentiated inhibitory protein (CPI- 
17) which phosphorylates the protein phosphatase (PP1) subunit of MLC phosphatase 
resulting in dissociation and inactivation of the enzyme. Recent studies suggest,
9_l_
however, that PKC does not play a major role in Ca -sensitization. RhoA activates ROK 
which phosphorylates and inhibits MYPT1. Some studies suggest that ROK can also 
activate CPI-17 and directly phosphorylate myosin light chains at the same site as MLC
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kinase. It is currently thought that direct phosphorylation of MYPT1 is the primary Ca2+- 
sensitizing action of ROK (reviewed by 22).
K+-depolarization (KCI) of smooth muscle, like receptor activation, causes an 
increase in [Ca2+]i, but KCl-stimulation does not cause activation of G protein-coupled 
receptors. Thus, KCI is used to induce contractile protein activation independently of 
plasma membrane receptor activation. Recent studies suggest that KCI can also produce 
an increase in the Ca2+-sensitivity of arteries (38, 36). Our laboratory has previously 
shown that KCl-induced contraction can be desensitized. Upon pretreatment of arteries 
with receptor agonists, the degree of force produced for a given KCl-induced increase in 
[Ca2+]i can be substantially altered (40,41). This is also true for receptor-induced Ca2+- 
sensitivity (41). Since desensitization of KCl-induced contractions suggests that the 
smooth muscle cells stored information about the previous receptor activation, we termed 
this phenomenon non-neuronal cell memory. Moreover, we found that in naive arteries, 
receptor agonists cause a greater degree of Ca2+-sensitization than KCI (41).
Thus, receptor- and KCl-induced contractile mechanisms share at least one
9+feature, namely, the degree of Ca -sensitivity induced upon muscle stimulation is 
dependent on the history of receptor stimulation. We propose that this shared feature
9+ • • •reflects a common subcellular mechanism regulating Ca -sensitivity. The present study
9+is an investigation of mechanisms regulating the Ca -sensitization produced by KCI and 
the Ca2+-desensitization of KCl-induced contractions in non-neuronal cell memory.
Y-27632 is known to be a highly selective inhibitor o f ROK. The concentrations 
of Y-27632 required for 50% inhibition of phenylephrine-contracted aorta (ICso) and 
50% inhibition of isolated ROK (Ki) are, respectively, 0.7 pM and ~0.1-0.8 pM
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(80,31,81,82). HA-1077, another potent inhibitor o f ROK, has a Ki o f 2-11 pM for ROK, 
and neither Y-27632 nor HA-1077 significantly inhibits MLC kinase or PKCa activities 
at the concentrations used in the present study (81,83). We found that tonic force 
produced by KCI in rabbit arteries was inhibited -50%  by 1 pM Y-27632 and more than 
60% by 10 pM HA-1077, whereas early peak force was not affected by either ROK 
inhibitor. Likewise, early peak MLC phosphorylation was unaffected by 1 pM Y-27632, 
whereas 1 pM nifedipine nearly abolished both peak and tonic force and MLC 
phosphorylation.
Given the high selectivity of Y-27632 and HA-1077 for ROK inhibition, these 
data suggest that ROK did not participate in early force development, but played an 
essential role in the maintenance of KCl-induced steady-state force. Moreover, KCl- 
induced increases in [Ca2+]i were not affected by 1 pM Y-27632, but MLC 
phosphorylation was. These data indicate that at this concentration, Y-27632 did not act 
as a Ca2+ channel blocker to reduce MLC phosphorylation and force. The Ca2+ channel 
blocker, nifedipine, inhibited both peak and tonic MLC phosphorylation and force,
9 4 -supporting a role for Ca in early force development and delayed activation of ROK 
leading to tonic force maintenance.
Although Y-27632 is highly selective for inhibition of ROK, a recent study 
revealed that 1 pM Y-27632 can also inhibit PKC8, a novel PKC isotype (32). However, 
PKC8 is also strongly inhibited by 1 pM GF-109203X, a staurosporine analog that is 
used to concentration-dependently inhibit conventional and novel isoforms of PKC 
(71,70,32). In the present study, 1 pM GF-109203X had no effect on KCl-induced 
contraction (see Figs 2B and 2C). Together, these data support the hypothesis that PKC
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does not play a role in KCl-induced tonic force maintenance, but that a common 
mechanism shared by KCI and receptor agonists is activation o f ROK.
To induce Ca2+-sensitization, ROK must interact with the plasma membrane 
(reviewed by 21), and recent studies suggest that small plasma membrane invaginations, 
named caveolae, are major centers for coordination of cellular signal transduction. 
Caveolae contain multiple receptors, signal transduction molecules, voltage-gated ion 
channels, and numerous effectors (reviewed by 54,58,53,57). Caveolins, the structural 
proteins of caveolae, act as scaffolds for assembly and interaction o f signaling molecules 
at caveolae (reviewed by 58).
That caveolae are loci for receptor agonist-induced Ca2+-sensitization was 
proposed recently (57). Furthermore, it was shown that receptor agonist-stimulation of 
smooth muscle causes a redistribution of RhoA, ROK and PKCa from the cytosol to the 
cell periphery (42). The present study extends this model to include K+-depolarization as 
a stimulus that also causes ROK translocation to caveolae at the plasma membrane of 
rabbit arterial smooth muscle.
In this study, we found that the amount of ROK colocalized with caveolin at the 
cell periphery doubles from basal levels upon contraction with either KCI or the L-type 
calcium channel agonist Bay K-8644. Moreover both receptor agonists and KCI cause 
increases in [Ca2+]j and our data support the hypothesis that Ca2+plays an essential role in 
KCl-induced ROK translocation. This is because the Ca2+ channel blocker, nifedipine, 
and the calmodulin blocker, trifluoperazine, when used at concentrations that are known 
to inhibit contraction (84), prevented KCl-induced ROK translocation to caveolae.
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The fact that nifedipine concentration-dependently inhibited KCl-induced ROK
9 +translocation further supports a role for Ca in the regulation of ROK activation and 
concomitant force maintenance. Moreover, 1 pM Y-27632 inhibited Bay K-8644- and 
calcium ionophore (ionomycin)-induced MLC phosphorylation and force. Nifedipine did 
not inhibit ionomycin-induced increases in ROK translocation and force which suggests 
that the contraction elicited by ionomycin involved Ca2+ entry that was independent of L- 
type calcium channels. Furthermore, the Ca2+ entry elicited by ionomycin was sufficient 
to cause ROK translocation. Though G proteins have been shown to cause Ca2+- 
sensitization, these data strongly support a role for an increase in [Ca2+]j, a common 
feature of both receptor activation and KCI contraction, in the pathways leading to Ca2+- 
sensitization.
Receptor agonists produce a greater degree o f Ca2+-sensitization than KCI, and 
these data could suggest a mechanism for the observed differences in Ca2+-sensitization. 
The differences could involve the activation of PKC, which plays a role in receptor 
agonist-induced Ca2+-sensitization, but which we did not find to participate in KCI-
9 +induced Ca -sensitization. Furthermore, our data show that 30% of RhoA is colocalized 
with caveolin basally (Fig 11), whereas others suggest that the translocation of RhoA 
elicited by receptor agonists to the cell membrane is required for its Ca2+-sensitizing 
actions and that receptor agonists cause an increase in RhoA at the plasma membrane 
(42, and reviewed by 1). Taken together these data suggest a novel model for Ca2+- 
activated Ca2+-sensitization, elicited by KCI contraction, that involves Ca2+/cam 
dependent ROK translocation to caveolae to be activated by the RhoA already there (Fig 
20).
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Figure 20. Model of Ca -activated Ca -sensitization.
Our laboratory has shown that the degree of force produced for a given KCI- 
induced increase in [Ca ]i can be substantially altered by the history of receptor 
stimulation. For example, femoral arteries were contracted with a maximum 
concentration (10'5M) of the a-adrenoreceptor agonist phenylephrine (PE) and relaxed by 
10 minute PE washout. During a subsequent KCI contraction, the tonic force and 
increases MLC phosphorylation, but not increases in[Ca2+], are reduced by 60 % when 
compared to nai've tissues not previously contracted with PE (40). We termed this 
phenomenon non-neuronal cell memory, because the vascular smooth muscle cells stored 
information temporarily about the degree of prior activation (85). Non-neuronal cell 
memory could play a role in maintaining vasodilation o f arteries when factors normally 
responsible for relaxing the smooth muscle cells are not functioning. For example, if  the
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vascular endothelial cells are damaged and unable to produce nitric oxide to maintain the 
proper state o f vasodilation, non-neuronal cell memory could protect the artery from 
excess contraction that could deprive the downstream organ or tissues o f blood. Previous 
data from our laboratory shows that pretreatment of arteries with PE reduced the ability 
o f histamine to cause a subsequent contraction (41). In this way non-neuronal cell 
memory could serve as a protective mechanism, or a redundant system in arteries if  the 
endothelial-derived vasodilatory apparatus is working properly, so that proper blood flow 
is maintained. The precise subcellular mechanism causing non-neuronal cell memory 
remains to be elucidated, but this study was designed to investigate the possibility that 
Ca2+-desensitization elicited in non-neuronal cell memory involves an inhibition of the 
signaling pathways involved in Ca2+-sensitization.
We found that, unlike control tissues showing a robust increase in ROK 
translocation at 30 seconds of KCl-stimulation, tissues pretreated with PE showed no 
increase in ROK translocation to caveolin when subsequently stimulated with KCI for 30 
seconds. Moreover, whereas -30%  of RhoA is colocalized to cavelin basally, in tissues 
not previously contracted with PE, RhoA colocalization to caveolin was decreased below 
the basal level at 30 minutes of PE contraction and remained below the basal level during 
the subsequent KCI contraction (Fig 12B). Together these data provide a molecular 
explanation for non-neuronal cell memory in vascular smooth muscle. The data suggest 
that the inhibition of KCl-induced force maintenance by PE-pretreatment involves both 
an inhibition of the stimulus-induced increases in ROK translocation to caveolae and a 
decrease in RhoA available for activation of ROK at caveolae. Moreover, these data 
suggest that inhibition of the RhoA/ROK system, which has been shown to play a major
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role in Ca2+-sensitization, is part of the information storage mechanism in non-neuronal 
cell memory.
Previously our laboratory reported that non-neuronal memory is reversible, such 
that the degree o f downregulation to a subsequent contraction is dependent on the 
concentration of PE used during the pretreatment episode and the duration of the washout 
period (41). Our lab previously showed that a high PE concentration (10 pM) resulted in 
inhibition of histamine-induced force, but a low concentration (1 pM) did not reduce 
force when compared to tissues that were not pretreated. Additionally, a PE washout 
period longer that 90 minutes, reversed the desensitization induced by PE pretreatment 
(41).
In the present study, pretreatment with a sub-maximal concentration of PE (0.1 
pM) and increasing the PE washout time to 2 hours resulted in a doubling o f ROK 
colocalization to caveolin at 30 seconds of KCI contraction. Thus, the degree of KCl- 
induced ROK translocation to caveolin at 30 seconds in naive (those not pretreated) was 
the same as pretreated arteries if  the concentration of the PE stimulus was decreased from 
lOpM to 0.1 pM, and if the washout time was increased from 10 minutes to 2 hours.
These data demonstrate that non-neuronal cell memory is a reversible phenomenon and 
further support a role for the RhoA/ROK pathway in non-neuronal cell memory.
Endothelial nitric oxide (NO) causes relaxation of vascular smooth muscle and 
vasodilation, and its actions are mediated by an increase in cGMP. PKG is known to 
mediate the actions o f cGMP (49). PKG causes Ca2+-desensitization by 
dephosphorylation of myosin light chains (44,45,46,47), and recent data also suggest that 
PKG phosphorylation of active RhoA results in its removal from the membrane.
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Phosphorylation o f RhoA increases its interaction with RhoGDI and stabilizes it in the 
inactive form (49).
These data show that 8br-cGMP, a cell permeable activator of PKG, prevented the 
increase in ROK colocalization to caveolin produced at 30 seconds by KCI and PE. 
Furthermore increased PKG activity resulted in a decrease in the basal level of RhoA 
colocalized with caveolin from -28%  to ~18% (Fig 13B). In tissues treated with 8br- 
cGMP there was no increase in RhoA colocalization to caveolae upon stimulation with 
KCI or PE. Thus, increased PKG activity not only resulted in an inhibition of ROK 
translocation, but also caused a decrease in active RhoA at the membrane. The similarity 
of these data to that determined following PE (10pM) pretreatment could suggest that a 
common mechanism for desensitization of the KCI response, with both PKG activity and 
non-neuronal cell memory, is inhibition of the RhoA/ROK signaling pathway.
Furthermore, in arteries treated with 8br-cGMP there was an increase in the 
colocalization of RhoA with RhoGDI. An increase in RhoA and RhoGDI colocalization 
was also found in arteries at 30 minutes of PE contraction and at 30 seconds of a 
subsequent KCI contraction. These data support the work of others which showed that 
PKG stabilizes the inactive conformation of RhoA and suggest that RhoA is similarly 
inactivated during non-neuronal cell memory.
Desensitization to KCl-induced increases in force and [Ca2+]i in femoral arteries 
is also caused by the PP1 inhibitors such as okadaic acid (OA). Others have shown that 
OA treatment results in kinase-dependent caveolae internalization (64). Recent studies 
propose caveolae as a site for coordination of signaling pathways, so it is possible that 
caveolae disruption could inhibit signaling pathways that utilize caveolae for signal
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coordination. In this study, we found that treatment of arteries with OA and NaF 
abolished the colocalization or ROK to caveolin at 30 seconds of KC1 contraction 
suggesting that PP1 inhibition caused desensitization of the KC1 response in part through 
an alteration of the RhoA/ROK signaling pathway. These data support a role for intact 
caveolae in the RhoA/ROK pathway leading to Ca2+-sensitization.
To determine whether PP1 inhibition with OA resulted in internalization of 
caveolae, we determined the amount of caveolin colocalized with the nucleus. The data 
revealed that treatment with OA and NaF doubled the amount of caveolin colocalized 
with the nucleus from basal levels.
We also found that increased PKG activity, elicited by 8br-cGMP, increased 
caveolin colocalization with the nucleus. Thus, we suggest a novel role for PKG in 
caveolar internalization which supports the work of others who propose that caveolar 
maintenance is kinase-dependent. PE pretreatment (non-neuronal cell memory) did not 
cause caveolar internalization. Thus, our data suggest that inhibition o f the RhoA/ROK 
signaling pathway rather than a disruption of caveolae is the information storage method 
utilized in non-neuronal cell memory and not a disruption of caveolae.
A recent study demonstrated that caveolae are also under the dual control of actin 
filaments and microtubules (63). The authors show that microtubules are responsible for 
maintaining the depth of caveolar invagination. They further hypothesize that transport 
of proteins to caveolae is controlled by actin filaments (63). Because in the present study 
we found that intact caveolae are necessary for RhoA/ROK-mediated Ca2+-sensitization, 
we investigated the role of cytoskeletal elements on the RhoA/ROK signaling pathway. 
The disruption of actin filaments with cytochalasin D decreased ROK translocation at 30
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
64
seconds of KC1 contraction by -50% . Depolymerization of microtubules with 
nocodazole also decreased ROK translocation. These data support the work of others 
that demonstrates a role for actin fdaments in transporting proteins to caveolae, but our 
data also suggest that microtubules play a role in ROK mediated signaling in smooth 
muscle.
In summary, we propose a novel model for Ca2+-sensitization. We found that 
ROK translocation to caveolae is elicited by KC1. Moreover we found that 30% of RhoA 
is colocalized to caveolin basally, and that PKC does not play a role in KCl-induced tonic 
force maintenance. These data when taken together suggest that an increase in [Ca2+];,
9+which is a component o f receptor activation, causes Ca -sensitization. Furthermore our 
novel model of Ca2+-activated Ca2+-sensitization, suggests two mechanisms for the 
difference in the degree of Ca2+-sensitization produced by receptor agonists and KC1.
First we determined that PKC does not play a role in KCl-induced Ca2+-sensitization, and 
second we found there is not an increase in RhoA colocalization to caveolin above the 
30% there basally.
We also suggest that the information storage method utilized in non-neuronal cell 
memory involves an inhibition of the RhoA/ROK pathway. Specifically, PE 
pretreatment causes an inhibition of ROK translocation to caveolae in the subsequent KC1 
contraction and also results in an increase in inactive RhoA. The finding, in this study, 
that PKG activation also leads to a similar inhibition of the RhoA/ROK signaling 
pathway suggests a common mechanism for Ca2+-desensitization. The desensitization 
elicited by PP1 inhibition involved an internalization of caveolae and an inhibition of 
ROK translocation. These data support the hypothesis that caveolae are loci for signal
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transduction pathways, but also suggests that the membranous location of caveolae is an 
important factor in RhoA/ROK-mediated Ca2+-sensitization. The finding that PKG 
activation leads to caveolar internalization supports the hypothesis that caveolar 
maintenance is kinase mediated, but the precise signals involved in PKG-mediated 
caveolar internalization were not determined.




These data suggest that increases in [Ca2+]i rather than strong membrane 
depolarization, per se, caused translocation of ROK to caveolae. Y-27632 did not prevent 
KCl-induced ROK translocation at 30”, but did inhibit KCl-induced tonic (i.e., 5’) 
contraction, suggesting that ROK activation may not be required to cause ROK 
translocation. Moreover, KCl-induced ROK translocation to the plasma membrane 
preceded the ability of Y-27632 to inhibit force. Thus, we suggest that an increase in 
[Ca2+]; can induce Ca2+ sensitization by causing Ca2+-dependent ROK translocation to 
caveolae for activation by RhoA that is found there basally.
However, these data do not rule out additional signaling events that may be 
coordinated at the cell membrane, such as activation o f ZIP-like kinase (86) which has 
been shown cause sustained MLC phosphorylation and force in the face o f temporally 
falling [Ca2+]i. Thus, a future direction of this research could be to investigate the role of 
possible downstream effectors of ROK, and their precise effect on MLC phosphatase and 
Ca2+-sensitization in smooth muscle.
Furthermore, receptor agonists produce a greater increase in Ca2+-sensitivity than 
KC1 (41). Data suggest that receptor agonists cause stronger increases in ROK activity 
through additional translocation of RhoA to caveolae (reviewed by (21)), or by activating 
additional Ca2+-sensitizing mechanisms involving PKC (42, 32) that are independent of 
increases in [Ca2+]j (34). Though these data suggest two mechanisms for differences in 
the degree o f Ca2+-sensitization elicited by KC1 contractions and receptor agonists, it
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remains to be determined whether these are the only mechanistic differences between 
these Ca2+-sensitizing stimuli.
Our laboratory has previously shown that the degree of Ca2+-sensitization elicited 
by both receptor agonists and KC1 is dependent on the history o f receptor activation (non­
neuronal cell memory) (41). In this study, our data demonstrate an inhibition of ROK 
translocation to caveolae, and a decrease in RhoA colocalization with caveolin as 
mediators of Ca2+-desensitization. These data suggest that an inhibition of the 
RhoA/ROK signaling pathway is a key to the information storage mechanism elicited in 
non-neuronal cell memory and desensitization of the KC1 response.
Others have shown that PKG activation, can cause Ca2+-desensitization by 
dephosphorylation of myosin light chains and inactivation of RhoA (44,45,49). Our data 
support a role for PKG in desensitization of the KC1 response. The data also demonstrate 
that a decrease in RhoA at the caveolae and an increase in RhoA colocalization with 
RhoGDI is a common feature in both PKG-mediated desensitization and non-neuronal 
cell memory. It remains to be determined if PKG plays a role in non-neuronal cell 
memory, but our data do suggest that inhibition of the RhoA/ROK signaling which leads 
to desensitization o f the KC1 response is a convergent point in these two signaling 
pathways.
Desensitization to KCl-induced increases in force and [Ca2+]i can also be elicited 
by the PP1 inhibitors okadaic acid and NaF. Our data suggests that OA also causes 
internalization of caveolar. These data support the work of others that indicate that 
caveolar maintenance is kinase-mediated. Moreover, these data demonstrate that intact 
caveolae are important in ROK-mediated Ca2+-sensitization, which supports the role for
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caveolar as major centers for coordination of signal transduction cascades in vascular 
smooth muscle.
The novel finding that PKG activation results in caveolar internalization supports 
the hypothesis that caveolar internalization is kinase-mediated. Also, these data 
demonstrates that both non-neuronal cell memory and PKG activation involve an 
inhibition of a common pathway (the RhoA/ROK signaling pathway) though the two 
methods of Ca2+-desensitization vary. Thus, caveolar internalization, due to PKG 
activity, may play a role in Ca2+-desensitization but it is only one facet of Ca2+- 
desensitization.
Our data also demonstrate that an intact cytoskeleton is necessary for Ca2+- 
sensitization. Since disruption of actin filaments abolished ROK movement, a future 
direction of this study could be to investigate the role of unconventional myosins moving 
along actin filaments in the process of protein translocation. Furthermore, the control of 
caveolar invagination, or depth, could be important to various signaling pathways as 
many receptors and channels are found there. In some cell types caveolae not only act at 
scaffolds at the cell membrane but also act as shuttles between organelles (reviewed by 
58, 54). Smooth muscle caveolae are relatively static structures at the membrane, but 
there is currently little information regarding the effect of the maintenance o f caveolar 
size and shape on the signaling pathways. Our data suggest that Ca2+ can induce Ca2+- 
sensitization, and it is known that much of the Ca handling machinery m smooth muscle 
cells is located in caveolae, including L-type Ca2+ channels (60). Thus, another future 
direction o f this work could be to investigate the role of caveolar internalization or 
disruption on Ca2+ signaling and the Ca2+ channels in smooth muscle.
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In summary, we propose a novel model for Ca2+-sensitization. We conclude that 
Ca2+ can induce Ca2+-sensitization by causing Ca2+/cam-dependent ROK translocation to 
caveolae and activation of ROK at the caveolae by the RhoA there basally. We conclude 
that the desensitization elicited in non-neuronal cell memory involves both an inhibition 
of ROK translocation as well as a decrease in RhoA colocalization with caveolin. We 
conclude that PKG-mediated Ca2+-desensitization, though also resulting in inhibition of 
the RhoA/ROK signaling in a manner similar to non-neuronal cell memory, involves 
internalization of caveolae which is not a component of non-neuronal cell memory. 
Furthermore, caveolar internalization elicited by PP1 inhibition and PKG activation Ca2+- 
desensitizes smooth muscle by inhibiting RhoA/ROK signaling. These data support the 
hypothesis that caveolae are centers for signal transduction, and we conclude that 
caveolae play a major role in coordinating Ca2+-activated, RhoA/ROK-mediated Ca2+- 
sensitization in arterial smooth muscle.
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